Gut microbiota in bariatric surgery.

Gut microbes bariatric surgery postbiotics prebiotics probiotics short-chain fatty acids virome

Journal

Critical reviews in food science and nutrition
ISSN: 1549-7852
Titre abrégé: Crit Rev Food Sci Nutr
Pays: United States
ID NLM: 8914818

Informations de publication

Date de publication:
2023
Historique:
medline: 13 11 2023
pubmed: 10 5 2022
entrez: 9 5 2022
Statut: ppublish

Résumé

Gut microbes share a symbiotic relationship with humans and perform several metabolic and physiological functions essential for human survival. It has been established in several scientific studies that obesity and other metabolic complications are always associated with disturbed gut microbiota profile, also called gut dysbiosis. In recent years, bariatric surgery has become a treatment of choice for weight loss, and it forms an important part of obesity management strategies across the globe. Interestingly, bariatric surgery has been shown to alter gut microbiota profile and synthesize short-chain fatty acids by gut microbes. In other words, gut microbes play a crucial role in better clinical outcomes associated with bariatric surgery. In addition, gut microbes are important in reducing weight and lowering the adverse events post-bariatric surgery. Therefore, several prebiotics, probiotics and postbiotics are recommended for patients who underwent bariatric surgery procedures for better clinical outcomes. The present review aims to understand the possible association between gut microbes and bariatric surgery and present scientific evidence showing the beneficial role of gut microbes in improving therapeutic outcomes of bariatric surgery.

Identifiants

pubmed: 35531940
doi: 10.1080/10408398.2022.2067116
doi:

Substances chimiques

Prebiotics 0

Types de publication

Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

9299-9314

Auteurs

Amin Gasmi (A)

Société Francophone de Nutrithérapie et de Nutrigénétique Appliquée, Villeurbanne, France.
Laboratoire Interuniversitaire de Biologie de la Motricité, Université Claude Bernard, Villeurbanne, France.

Geir Bjørklund (G)

Council for Nutritional and Environmental Medicine (CONEM), Mo i Rana, Norway.

Pavan Kumar Mujawdiya (PK)

Inochi Care Private Limited, New Delhi, India.

Yuliya Semenova (Y)

Department of Neurology, Ophthalmology, and ENT, Semey Medical University, Semey, Kazakhstan.
CONEM Kazakhstan Environmental Health and Safety Research Group, Semey Medical University, Semey, Kazakhstan.

Alexandru Dosa (A)

Ovidius University of Constanta, Constanta, Romania.

Salva Piscopo (S)

Société Francophone de Nutrithérapie et de Nutrigénétique Appliquée, Villeurbanne, France.
Department of Nutritional Research and Development, Nutri-Logics SA, Weiswampach, Luxembourg.

Joeri J Pen (JJ)

Diabetes Clinic, Department of Internal Medicine, UZ Brussel, Vrije Universiteit Brussel (VUB), Brussels, Belgium.
Department of Nutrition, UZ Brussel, Vrije Universiteit Brussel (VUB), Brussels, Belgium.

Asma Gasmi Benahmed (A)

Académie Internationale de Médecine Dentaire Intégrative, Paris, France.
Université Claude Bernard -Lyon 1, Villeurbanne, France.

Daniel-Ovidiu Costea (DO)

Ovidius University of Constanta, Constanta, Romania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH